Comparative genomics of Klebsiella pneumoniae strains with different antibiotic resistance profiles. 2011

Vinod Kumar, and Peng Sun, and Jessica Vamathevan, and Yong Li, and Karen Ingraham, and Leslie Palmer, and Jianzhong Huang, and James R Brown
Computational Biology, Quantitative Sciences, GlaxoSmithKline, King of Prussia, Pennsylvania, USA.

There is a global emergence of multidrug-resistant (MDR) strains of Klebsiella pneumoniae, a Gram-negative enteric bacterium that causes nosocomial and urinary tract infections. While the epidemiology of K. pneumoniae strains and occurrences of specific antibiotic resistance genes, such as plasmid-borne extended-spectrum β-lactamases (ESBLs), have been extensively studied, only four complete genomes of K. pneumoniae are available. To better understand the multidrug resistance factors in K. pneumoniae, we determined by pyrosequencing the nearly complete genome DNA sequences of two strains with disparate antibiotic resistance profiles, broadly drug-susceptible strain JH1 and strain 1162281, which is resistant to multiple clinically used antibiotics, including extended-spectrum β-lactams, fluoroquinolones, aminoglycosides, trimethoprim, and sulfamethoxazoles. Comparative genomic analysis of JH1, 1162281, and other published K. pneumoniae genomes revealed a core set of 3,631 conserved orthologous proteins, which were used for reconstruction of whole-genome phylogenetic trees. The close evolutionary relationship between JH1 and 1162281 relative to other K. pneumoniae strains suggests that a large component of the genetic and phenotypic diversity of clinical isolates is due to horizontal gene transfer. Using curated lists of over 400 antibiotic resistance genes, we identified all of the elements that differentiated the antibiotic profile of MDR strain 1162281 from that of susceptible strain JH1, such as the presence of additional efflux pumps, ESBLs, and multiple mechanisms of fluoroquinolone resistance. Our study adds new and significant DNA sequence data on K. pneumoniae strains and demonstrates the value of whole-genome sequencing in characterizing multidrug resistance in clinical isolates.

UI MeSH Term Description Entries
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D013420 Sulfamethoxazole A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208) Sulfamethylisoxazole,Gantanol,Sulfisomezole,Sulphamethoxazole
D014295 Trimethoprim A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported. Proloprim,Trimpex
D016680 Genome, Bacterial The genetic complement of a BACTERIA as represented in its DNA. Bacterial Genome,Bacterial Genomes,Genomes, Bacterial
D047090 beta-Lactams Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria. beta-Lactam,4-Thia-1-Azabicyclo(3.2.0)Heptanes,4-Thia-1-Azabicyclo(4.2.0)Octanes,beta Lactam,beta Lactams
D023281 Genomics The systematic study of the complete DNA sequences (GENOME) of organisms. Included is construction of complete genetic, physical, and transcript maps, and the analysis of this structural genomic information on a global scale such as in GENOME WIDE ASSOCIATION STUDIES. Functional Genomics,Structural Genomics,Comparative Genomics,Genomics, Comparative,Genomics, Functional,Genomics, Structural
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone
D024901 Drug Resistance, Multiple, Bacterial The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Drug Resistance, Extensive, Bacterial,Drug Resistance, Extensively, Bacterial,Extensive Antibacterial Drug Resistance,Extensively Antibacterial Drug Resistance,Multidrug Resistance, Bacterial,Multiple Antibacterial Drug Resistance,Bacterial Multidrug Resistance,Bacterial Multidrug Resistances,Resistance, Bacterial Multidrug

Related Publications

Vinod Kumar, and Peng Sun, and Jessica Vamathevan, and Yong Li, and Karen Ingraham, and Leslie Palmer, and Jianzhong Huang, and James R Brown
January 2021, Frontiers in cellular and infection microbiology,
Vinod Kumar, and Peng Sun, and Jessica Vamathevan, and Yong Li, and Karen Ingraham, and Leslie Palmer, and Jianzhong Huang, and James R Brown
August 2015, Genome biology and evolution,
Vinod Kumar, and Peng Sun, and Jessica Vamathevan, and Yong Li, and Karen Ingraham, and Leslie Palmer, and Jianzhong Huang, and James R Brown
October 2013, Pathologie-biologie,
Vinod Kumar, and Peng Sun, and Jessica Vamathevan, and Yong Li, and Karen Ingraham, and Leslie Palmer, and Jianzhong Huang, and James R Brown
May 2018, Pathogens and global health,
Vinod Kumar, and Peng Sun, and Jessica Vamathevan, and Yong Li, and Karen Ingraham, and Leslie Palmer, and Jianzhong Huang, and James R Brown
October 2017, Journal of applied microbiology,
Vinod Kumar, and Peng Sun, and Jessica Vamathevan, and Yong Li, and Karen Ingraham, and Leslie Palmer, and Jianzhong Huang, and James R Brown
January 2022, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale,
Vinod Kumar, and Peng Sun, and Jessica Vamathevan, and Yong Li, and Karen Ingraham, and Leslie Palmer, and Jianzhong Huang, and James R Brown
January 2018, Frontiers in medicine,
Vinod Kumar, and Peng Sun, and Jessica Vamathevan, and Yong Li, and Karen Ingraham, and Leslie Palmer, and Jianzhong Huang, and James R Brown
January 1980, Chemotherapy,
Vinod Kumar, and Peng Sun, and Jessica Vamathevan, and Yong Li, and Karen Ingraham, and Leslie Palmer, and Jianzhong Huang, and James R Brown
June 2017, Genomics data,
Vinod Kumar, and Peng Sun, and Jessica Vamathevan, and Yong Li, and Karen Ingraham, and Leslie Palmer, and Jianzhong Huang, and James R Brown
October 2001, Indian journal of pathology & microbiology,
Copied contents to your clipboard!